9A and B, respectively). This observation indicates that vaccinated mice still require lymphocyte re-circulation to mount an effective immune response on subsequent challenge. This finding further Pictilisib in vitro corroborated our initial conclusions Modulators regarding the importance of re-circulation

activity, even for the vaccine-supported protective immune response, as seen in this second mouse model of acute infection. The CD8+ T-cell immune response elicited by T. cruzi infection in most inbred mouse strains can control multiplication of this intracellular pathogen and preclude acute-phase pathologies such as death [1], [10], [11], [12], [13], [14], [15], [16] and [17]. The time at which acquired immunity develops is highly dependent on the parasite load [12] and [32]. In our model, with the Y strain of T. cruzi, we observed that the CD8+ T-cell immune response is only 3-deazaneplanocin A mw triggered at the time of the peak parasitemia [10] and [12]. Because the number of circulating parasites at this time is high, antigen presentation could occur in the draining LN or the spleen. However, the results of our experiments that involved the use of the immunosupressive drug FTY720, in combination with the identification of activated CD11c+ cells, found mostly in the LN, clearly demonstrated that the LNs draining the parasite

entrance are where the specific CD8+ T cells are primed. Then, they exit the LN and reach the spleen. Our results are similar to those of experimental vaccination studies with radiation-attenuated

malaria parasites [33]. In this case, the CD8+ T-cell response originates in the LN draining site at the site of parasite entrance in the skin, and then these cells migrate to other peripheral organs. Ketanserin Similar to our results, exposure to FTY720 led to accumulation of specific T cells in the draining LN and a ∼85% reduction of the specific CD8+ T cells in the spleen [33]. Together, these results provide compelling evidence that the priming of CD8+ T cells can take place in the local lymphoid tissue during protozoan infection/vaccination and that a rapid re-circulation to the spleen is likely to occur. As in our case, the authors conclude that this rapid re-circulation during infection was critical for protective immunity mediated by malaria-specific CD8+ T cells [33]. Both studies used parasites that infect mice (T. cruzi or Plasmodium yoelii). Nevertheless, it is important to highlight that only T. cruzi infects humans. Also, the studies of malaria used radiation-attenuated parasites as vaccine because they do not cause infection. Therefore, it is unknown whether the same occurs during acquired immunity to experimental infection as in our case. These observations with T. cruzi and malaria parasites stand in contrast to other pathogens.